Changes in Quality of Diabetes Care and Morbidity over 20 Years in People with Type 1 Diabetes and Long Diabetes Duration: The JEVIN Trial

Abstract

Background: The JEVIN trial started as a cross-sectional study in 1989/90 in Jena, a city of the former German Democratic Republic. At that time, the centralized diabetes care system was broken down and restarted 10 years later; structured treatment and teaching programs were implemented, blood glucose self-monitoring, insulin pump-systems and analogue insulin were introduced. We surveyed people with type-1-diabetes of the baseline JEVIN trial in a 20-year follow-up.

Methods: 131 patients with type-1-diabetes were analyzed in 1989/90. Of the living population in 2009/10 (n=104), 83 persons were identified and 75 persons with a mean diabetes duration of 35 years were reexamined regarding HbA_1c, self-monitoring, diabetes therapy, severe hypoglycemia, diabetic late complications and compared with the results of the same persons in 1989/90.

Results: HbA_1c decreased from 57.1 mmol/mol in 1989/90 to 52.7 mmol/mol in 2009/10 (7.4 –7.0%; p=0.049). Self-monitoring of blood glucose increased from 2 to 35 tests/week (p<0.001). 100%-use of animal insulin changed to human and analogue insulin therapy. The incidence of severe hypoglycemia increased from 0.1 to 0.16/patient-year. Retinopathy increased from 29 to 69% (p<0.001), nephropathy from 5 to 27% (p<0.001) and neuropathy from 13 to 43% (p<0.001). 17% had no diabetic late complications.

Conclusions: The JEVIN trial shows a significant improve in HbA_1c in the past 20 years. Severe hypoglycemia occurred rarely and 17% were still free of any diabetic late complication after 35 years of diabetes. This indicates a good quality of diabetes care in a German setting.

Key words

hypoglycaemia - HbA1c - observational study - Germany - diabetic late complications

• References

• 1 Müller UA, Ross IS, Klinger H et al. Quality of centralized diabetes care: a population based study in the German Democratic Republic 1989–1990. Acta Diabetol 1993; 30: 166-172
• 2 Piwernetz K, Home PD, Snorgaard O et al. for the DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee . Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE Initiative. DMe 1993; 10: 371-377
• 3 Schiel R, Müller UA. Die Stoffwechselqualität von insulinbehandelten Patienten mit Diabetes mellitus in einer mitteldeutschen Stadt 1989/90 bis 1999/2000 Die JEVIN-Studie. Medizinische Klinik 2003; 98: 303-312
• 4 Schiel R, Müller UA, Sprott H et al. The JEVIN-Trial: A population-based survey on the quality of diabetes care in Germany: 1994/1995 compared to 1989/1990. Diabetologia 1997; 40: 1350-1357
• 5 Kassenärztliche Vereinigung Thüringen . 1998 Modellversuch Vereinbarung über eine strukturierte und qualitätsgesicherte ambulante Versorgung von Patienten mit Diabetes mellitus zwischen der Kassenärztlichen Vereinigung Thüringen und der AOK Thüringen. Germany, Anlage 3, RS III/1998
• 6 Grüßer M, Hartmann P, Jörgens V. Behandlungs- und Schulungsprogramm für Typ 1 Diabetiker. Mainz: Kirchheim; 1996
• 7 Mühlhauser I, Bruckner I, Berger M et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study. Diabetologia 1987; 30: 681-690
• 8 Berger M, Grüßer M, Jörgens V et al. Behandlungs- und Schulungsprogramm für Typ II Diabetiker, die Insulin spritzen. Köln: Deutscher Ärzte-Verlag; 1994
• 9 Mühlhauser I, Bott U, Overmann H et al. Liberalized diet in patients with type 1 diabetes. JInternMed 1995; 237: 591-597
• 10 Heller S, Kozlovski P, Kurtzhals P. Insulin’s 85^th anniversary – An enduring medical miracle. Diabetes Res Clin Pract. 2007; 78: 149-158
• 11 DCCT Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM 1993; 329: 977-986
• 12 Dulon M, Bardehle D, Blettner M. Assessing social inequality in microcensus data and German National Health Examination Survey. Gesundheitswesen 2003; 65: 629-635
• 13 Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
• 14 Young MJ, Boulton AJM, Macleod AF et al. A multicenter study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154
• 15 IBM Corp . Released 2011. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp;
• 16 R Core Team . R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2016. URL https://www.R-project.org/ download 03.2016
• 17 Nathan DM. DCCT/EDIC Research Group . The diabetes control and complications trial/Epidemiology of diabetes interventions and complications study at 30 years: Overview. Diab Care 2014; 37: 9-16
• 18 Orchard TJ, Nathan DM, Zinman B et al. The DCCT/EDIC Research Group. Association between seven years of intensive treatment of type 1 diabetes and long term mortality. JAMA 2015; 313: 45-53
• 19 Jacobson AM, Braffett BH, Cleary PA et al. DCCT/EDIC Research Group. The long-term effects of type 1 diabetes treatment and complications on health-related quality of life. Diab Care 2013; 36: 3131-3138
• 20 Miller RG, Secrest AM, Sharma RK et al. Improvements in life expectancy of type 1 diabetes – The Pittsburgh Epidemiology of Diabetes Complications Study Cohort. Diabetes 2012; 61: 2987-2992
• 21 Pambianco G, Costacou T, Ellis D et al. The 30-year natural history of type 1 diabetes complications – The Pittsburgh Epidemiology of Diabetes Complications Study Experience. Diabetes 2006; 55: 1463-1469
• 22 Alberti KG, Gries FA. Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view. Diabet Med 1988; 5: 275-281
• 23 Böhm SO, Dreyer M, Fritsche A et al. Therapie des Typ-1-Diabetes. Herausger: Matthaei S, Kellerer M. Deutsche Diabetes Gesellschaft DDG, Version 1.0; September/2011
• 24 Calvert M, Shankar A, McManus RJ et al. Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ (Clinical Research Ed.) 2009; 338: b1870
• 25 Sämann A, Lehmann T, Heller T et al. A retrospective study on the incidence and risk factors of severe hypoglycemia in primary care. Family Practice 2013; 30: 290-293
• 26 Amiel SA, Pursey N, Higgins B et al. on behalf of the Guidelines Development Group . Diagnosis and management of type 1 diabetes in adults: summary of updated NICE guidance. BMJ 2015; 351: h4188
• 27 Müller N, Schiel R, Osterbrink B et al. Care and Outcome in Patients with Diabetes Mellitus Type 1 and Type 2 in Specialized Practice, Diabetes Specialized Hospital and Diabetes Department of a Regional General Hospital in Germany 2005. Diabetologie und Stoffwechsel 2008; 3: 41-50
• 28 Donnelly LA, Morris AD, Frier BM et al. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med 2005; 22: 749-755
• 29 U.K. Hypoglycaemia Study Group . Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50: 1140-1147
• 30 Pedersen-Bjergaard U, Pramming S, Heller SR et al. Severe hypoglycemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004; 20: 479-486
• 31 Deutsche Diabetes Gesellschaft (DDG) Richtlinien zur Anerkennung einer Behandlungseinrichtung „Zertifiziertes Diabeteszentrum DDG“. Ausschuss Qualitätssicherung, Schulung und Wieterbildung (QSW), Fassung vom 23.07.2014. Download http://www.deutsche-diabetes-gesellschaft.de/zertifizierung/diabeteszentrum-ddg/richtlinien.html am 01.07.2016
• 32 Seaquist ER, Anderson J, Childs B et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013; 36: 1384-1395
• 33 Sämann A, Mühlhauser I, Bender R et al. Glycemic control and severe hypoglycemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementaion study. Diabetologia 2005; 48: 1965-1970
• 34 Fullerton B, Jeitler K, Seitz M et al. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus (review). Cochrane Database Syst Rev 2014; 14: CD009122
• 35 Klein R, Klein BEK, Moss SE et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520-526
• 36 Nathan DM, Zinman B, Cleary PA et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience (1983-2005). Arch Intern Med. 2009; 169: 1307-1316
• 37 Aiello LP. for the DCCT/EDIC Research Group . Diabetic retinopathy and other ocular findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care 2014; 37: 17-23
• 38 Kähler P, Grevstad B, Almdal T et al. Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. BMJ Open 2014; 4: e004806 DOI: 10.1136/bmjopen-2014-004806.
• 39 Heller T, Blum M, Spraul M et al. Diabetic co-morbidities: prevalences in Germany. Dtsch Med Wochenschr 2014; 139: 786-791
• 40 Hagen B, Altenhofen L, Groos S et al. Qualitätssicherungsbericht 2013 – Disease Management Programme in Nordrhein. Herausgeber: Nordrheinische Gemeinsame Einrichtung Disease Management Programme GbR 2013